Impairment of pulmonary microvascular endothelial cells: The ground for COPD?

Hui Qi,Yunlong Hou,Ningxin Han,Peipei Jin,Jing Guo,Tongxing Wang,Zhenhua Jia
DOI: https://doi.org/10.1097/cm9.0000000000003280
IF: 6.133
2024-10-05
Chinese Medical Journal
Abstract:To the Editor : Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by abnormalities in the airways (bronchitis and bronchiolitis) and alveoli (emphysema), as well as pulmonary inflammation, leading to persistent and progressive airflow obstruction. [ 1 ] Pulmonary microvascular endothelial cells (PMECs), the main component of pulmonary microvasculature, accounts for about 23% of the human lung cells. PMECs play a pivotal role in the progression of COPD by maintaining lung homeostasis and being involved in various pathogenic processes. Firstly, PMECs are essential for the integrity of the pulmonary blood–gas barrier, facilitating efficient gas exchange. Damage to the PMECs disrupts this barrier, leading to increased permeability, edema, and impaired gas exchange, which are hallmark features of COPD. Secondly, PMECs regulate inflammatory responses by releasing cytokines and chemokines that attract immune cells. Dysfunctional PMECs in COPD contribute to chronic inflammation and subsequent lung tissue damage, exacerbating disease progression. Additionally, PMECs are crucial in pulmonary vascular remodeling, where endothelial dysfunction and apoptosis lead to structural changes, increased pulmonary vascular resistance, and pulmonary hypertension. PMECs are also highly susceptible to oxidative stress, which induces reactive oxygen species production and apoptosis, disrupting vascular integrity and promoting emphysema. Lastly, PMECs possess repair and regeneration capabilities, but chronic exposure to damaging stimuli in COPD impairs these processes, highlighting the importance of maintaining PMEC function to mitigate disease progress. Therefore, impairment of PMECs leads to vascular barrier defects, alveolar damage, and pulmonary inflammation, which are preceding the decline in lung function, thereby indicating that PMEC injury is pivotal in COPD development and progression.
medicine, general & internal
What problem does this paper attempt to address?